Clinical trial
Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ…
NCT00204789 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00204789 |
|---|---|
| Title | Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients |
| Official title | Phase 2b Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients (OTR) |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Post-solid Organ Transplant, Skin Neoplasms |
| Intervention type | Drug |
| Interventions | Difluoromethylornithine |
| Enrollment | 52 |
| Start date | Jul 1, 2003 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 16, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: